The Present Study was conducted in department of Medicine, Govt. Medical College, jammu, Where a total of 41 patients-29 males and 12 females-fulfilled the inclusion criteria of ADPKD, were gathered during the period of 1 year starting from Nov. 2011 to Oct. 2012. All the patients were subjected to a detailed history, clinical examination and laboratory investigations. X-ray chest (PA view), ECG and ultrasound of abdomen for kidneys, liver and spleen were done. Intravenous pyelogram and CT scan of abdomen was done when a definitive diagnosis of (ADPKD) could not be made on abdominal ultrasound. Echocardiography was done to evaluate cardiac murmurs and associated mitral valve prolapse, based on standard criteria. Male to female patients with ADPKD was 2.42:1. Maximum 17 (41.5%) patients of both gender were seen in 30 -40 years age group, Family history of ADPKD was present in 18 (43.9%) patients; Hypertension, alone or in combination with renal failure, was present in 65.8% patients; Hypertension alone was present in 19 (46.3%) patients; 8 (19.5%) patients with hypertension had renal failure; Low back pain was present in 24 (58.5%) and abdominal pain in 22 (53.7%) patients; 15 (36.6%) patients presented with at least one episode of gross haematuria; Headache was experienced by 18 (43.9%) patients. On clinical examination, 24 (58.5%) were found to have palpable kidney and 10 (24.4%) had palpable liver. Spleen was palpable in 1 (2.4%) patient, Murmur of mitral valve prolapse was found in 2 (4.9%) Patients; 3 (7.3%) patients having left ventricular hypertrophy; mean Hb was 11.2 g/dL. The liver cysts were found in 24.4% of the patients; Out of 10 (24.4%) patients with hepatic cyst involvement, 1 patient each was found to have evidence of portal hypertension and evidence of hepatic cyst infection. In the present study, hypertension was most common presentation of this disease. So, control of hypertension is very important to prevent progression of this disease. Patients who are detected to have ADPKD should be regularly followed-up to prevent further progression by timely intervention. Also, family members of patients should be screened for disease and initiate treatment as early as possible.
Introduction
Autosomal dominant polycystic kidney disease (ADPKD) is a monogenic, multi-systemic disorder characterized by the development of renal cysts and various extra-renal manifestations. Although the disease begins in-utero, it may take several decades for the signs to surface and is a leading cause for end stage renal failure. It affects all ethnic groups worldwide with an estimated prevalence of approximately 1 in 800 live births [1] . Being an autosomal dominant disorder, the offspring runs a 50% risk 85% of the cases with its causative gene localized to the short arm of chromosome 16 in the PKD1 locus [5] . The PKD1 gene codes for polycystin-1 (PC1), which plays a vital role in cell-cell and cell-matrix interactions [6] .
The function of polycystins have been scrutinized to the greater extent in epithelial tissues of the kidneys, liver and vascular smooth muscle. Mutation in either polycystins leads to phenotype of ADPKD. The hallmarks of this inherited condition are massively enlarged kidneys caused by sustained expansion of innumerable fluid filled cysts ranging in equivalent size from a pea to a grapefruit. Cysts derive from microscopic tubule precursors. They are seen in liver (~80%), and with lesser frequency in pancreas (10%) and arachnoid membranes (~8%). Aneurysms occur approximately in 5% of patients with ADPKD and higher frequency in those with a family history of aneurysm (~20%).
Type 2 ADPKD caused by a mutation in the PKD2 gene accounts for about 10% -15% of the cases, with the defective gene located on chromosome 4 [7] The rest (around 5%) have a defect unrelated to either locations and may be accounted by spontaneous mutations. The PKD2 gene codes for polycystin-2 (PC2), which is involved in cell calcium signaling [4] . The occurrence of cysts and end-stage renal disease are delayed in PKD2 disease (mean age 74.0 as against 54.3 years in PKD1) [8] .
The disease is characterized by a variable renal disease progression and manifestation. The variable phenotypic expression of the disease within families (intra-familial variability) is often linked to the occurrence of a somatic mutation in the intact allele within epithelial tubular cells (2 nd hit hypothesis) [4, 9] . However, the inter-familial variability can be accounted by genetic heterogeneity (PKD1 versus PKD2). Genetic modifiers (any gene unlinked to the PKD1 or PKD2 loci whose genotype correlates with the ADPKD phenotype) also play a role as far as clinical manifestation and disease progression in PKD1 is considered [10] .
In ADPKD each epithelial cells within a tubule harbours a germ line mutation, yet only a tiny fraction of the tubules develop renal cysts. It is currently held that the cells are protected by the allele inherited from the parent without ADPKD. When this allele is inactivated by a somatic event (mutation or otherwise) within a solitary renal tubule cell, the cell divides repeatedly until a cyst develops, with an aberrant growth program causing endless expansion. The severity of ADPKD is thought to be a direct consequence of the number of times and the frequency with which this cytogenic process occurs within the kidneys over the life of the patient. Hyperplasia occurs in renal cyst epithelial cells. The hyperplastic cells cause an out pocketing of the tubule wall, with formation of saccular cyst that fills with fluid derived from glomerular filtrate that enters from the afferent tubule segment.
Progressive expansion eventually causes most of the emerging cysts to separate from the parent tubule, leaving an isolated sac that fills with fluid by transepithelial secretion. This isolated cyst expands relentlessly as a result of continued proliferation of the mural epithelium together with transepithelial secretion of NaCl and water into the lumen [11] . The expanding fluid filled tumor masses elicit secondary and tertiary changes within the renal interstitium evinced by thickening and lamination of tubule basement membranes, infiltration of macrophages and neovascularisation [12] . Fibrosis within the interstitium begins early in the course of disease. Thus, cysts function as autonomous structures and are responsible for progressive kidney enlargement in ADPKD.
Hypertension is a relatively early finding in ADPKD with an average onset at 30 years of age [13] . Proteinuria observed in those with large (mean combined renal volume 1190 ml) rather than small volume (578 ml) renal volumes, is also associated with a greater likelihood of a subsequent loss of renal function. The renal cysts develop in tiny fraction of nephrons (estimated to be less than 1%) of ADPKD, with a highly variable prevalence ranging from 10 to 88% [28] [29] [30] . Both in males and females patients liver function is well preserved and liver enzymes and bilirubin usually remain normal [31] . The potential for complications of hepatic cystic involvement in ADPKD is significant [32] .
Intracranial Aneurysm
Rupture of intracranial aneurysm (ICA) is one of the dreadest complication of ADPKD. The reported frequency ranges from 0% to 41% [33, 34] .
Cardiac Disease
Since initial report of [35] , cardiovascular abnormalities, including mitral and aortic valvular prolapse and regurgitation and annuloaortic ectasia have been considered important extrarenal manifestation of ADPKD.
Diverticular Disease
Both an increased prevalence and an increased risk of complications from complicated diverticular disease are features of ADPKD. [36] It has been found that the prevalence of diverticulosis to be 83% in ADPKD patients on hemodialysis versus 32% of controls with chronic renal failure and 38% of age and gender-matched controls.
Diagnosis and Screening
The diagnosis of ADPKD relies primarily on imaging modalities that include ultrasonography, Computed Tomography (CT) and Magnetic Resonance Imaging (MRI) [37] [38] [39] [40] . However, genetic testing is made use of in certain settings when a definitive diagnosis is required. The age of the patient, presence or absence of a family history of the disease, family history of other genetic disorders, clinical manifestations of the disease, as well as the number and types of renal cysts are significant details that help in the diagnosis of ADPKD [17] .
A Study was conducted which provide evidence for increased cardiac pre-load, as assessed by plasma atrial natriuretic factor and cardiac index [41] . Bourquia et al. (1989) [45] studied ADPKD patients with a positive family history for a cerebral event, including cerebral stroke and intracranial bleeding or known intracranial saccular aneurysms (ICA) to facilitate the defiition of subgroups who were at risk for ICA and to determine the prevalence of ICA in these subgroups.
Schrier Ecder and Schrier (2009) [52] reported that cardiovascular problems are a major cause of morbidity and mortality in patients with autosomal-dominant polycystic kidney disease (ADPKD).
Hadimeri Alam and Perrone (2010) [59] reported the overall outcomes of individuals with ADPKD after ESRD as compared with non-ADPKD patients.
Bae and Grantham (2010) [60] In a review article discussed the overwhelming evidence in support of the view that imaging is an invaluable tool to monitor the onset and progression of autosomal dominant polycystic kidney disease (ADPKD) and is well-suited to gauge the response of this disease to targeted therapy before renal function begins to decline.
Barua and Pei (2010) [61] reviewed the clinical utilities and limitations of the imaging-and molecular-based diagnostic tests, and outlined their approach for the evaluation of individuals suspected to have autosomal-dominant polycystic kidney disease (ADPKD). Chang et al. (2010) [62] compared intracerebral hemorrhage (ICH) and subarachnoid hemorrhage (SAH) in patients with autosomal-dominant polycystic kidney disease (ADPKD).
Chapman et al. (2010) [63] carried out a study on hypertension in autosomal dominant polycystic kidney disease (ADPKD).
Harris and Rossetti (2010) [64] reported that like Mendelian diseases, the presentation and progression of autosomal dominant polycystic kidney disease (ADPKD) vary widely in the population. Meijer et al. (2010) [65] evaluated the prevalence of renal abnormalities in 103 prevalent ADPKD patients (Ravine criteria) at different ages.
Mufti and Nalagatla (2010) [66] reviewed nephrolithiasis in autosomal dominant polycystic kidney disease (ADPKD).
Pirson (2010) [67] studied extrarenal manifestations of autosomal dominant polycystic kidney disease (AKPKD).
Qian (2010) [68] reported that isolated polycystic liver disease (PCLD) is an autosomal dominant disease with genetic and clinical heterogeneity. Rabbani et al. (2010) [69] reported a case of a renal transplant recipient who suffered an isolated Mycobacterium tuberculosis infection of a native polycystic kidney.
Zheng et al. (2010) [70] treated two uremic autosomal dominant polycystic kidney disease (ADPKD) patients who developed refractory ascites after 1 year on hemodialysis with continuous ambulatory peritoneal dialysis (CAPD).
Since no study related to ADPKD has been undertaken in Jammu region, this study was conducted to study the various manifestations related with this heritable disease.
Materials & Methods
The present prospective study on clinical profile of autosomal dominant polycystic kidney disease (ADPKD) was conducted in Postgraduate Department of Medicine, Government Medical College, Jammu for a period of one year w.e.f. November, 2011 to October, 2012. A total of 41 patients fulfilled criteria of ADPKD.
Methods
All patients were subjected to a detailed history, clinical examination and laboratory investigations which were recorded in the predesigned proforma for this study. The following points were considered while taking history:  Onset of symptoms  Underlying systemic disease  Haematuria (Table 1, Figure 1 )  Abdominal pain (Table 2, Figure 2 )  Abdominal mass  Headache (Table 3, Figure 3 )  Non-specific symptoms like weakness, fever, nausea/ vomiting, malaise  Shortness of breath/dyspnoea
Clinical Examination
Clinical examination was focused on general physical examination, blood pressure, altered level of conscious ness, pallor, abdominal mass, cardiovascular system to exclude valvular lesions and left ventricular hypertrophy. Exa- mination of all other systems, including CVS, CNS and respiratory system was done and recorded in the given proforma. All patients were subjected to investigations which included haemolobin, TLC, DLC, PBF, ESR, blood sugar, renal function tests-serum urea, serum creatinine, serum electrolytes (Na + , K + ), liver function tests-serum bilirubin, SGOT, SGPT, serum alkaline phosphatase, serum proteins, serum albumin, complete urine examination with special attention to proteinuria, sediment, specific gravity, 24-hour urinary protein, X-ray chest (PA view), ECG and ultrasound of abdomen for kidneys, liver and spleen ( Table 4) . Intravenous pyelogram and CT scan of abdomen was done in selected cases when a definitive diagnosis of autosomal dominant polycystic kidney disease (ADPKD) could not be made on abdominal ultrasound. The requirement for diagnosis of associated hepatic was the presence of at least one cyst in the liver. Echocardiography was done to evaluate cardiac murmurs and associated mitral valve prolapse, based on standard criteria.
Inclusion Criteria
 More male ADPKD patients (29; 70.73%) were observed than female ADPKD patients (12; 29.27%) during the study period.  Male to female ratio was 2.42:1.  Most male patients 12 (41.4%) were observed in 30 -40 years age group, followed by 11 (37.9%) in 41 - 
Discussion
Autosomal dominant polycystic kidney disease (ADPKD) is the most common form of polycystic kidney disease in which cysts are distributed throughout the cortex and medulla. The age of presentation in the present study was 30 -70 years (Table 5, Figure 4) . Glassberg et al. (1981) [71] in a study found that most cases of ADPKD were identified between 30 and 50 years of age.In the present study, the proportion of male to female patients with ADPKD was 2.42:1 (Table 6, Figure 5) . Rabbani et al. 2008) [72] found a ratio of 2.5:1 in a study conducted in Pakistan on 56 ADPKD patients.In the present study, family history of ADPKD was present in 18 (43.9%) (Patients. Rabbani et al. (2008) [72] found 44.6% patients of ADPKD with family history of ADPKD (Table 7). In the present study, hypertension alone or in combination with renal failure was present in65.8% patients (Table 8, Figure 6) . Out of 41 patients, hypertension alone was present in 19 patients (46.3%). 13 presented with renal failure, defined as presently elevated Table 6 . Genderwise distribution of ADPKD patients (Figure 5) . serum creatinine of greater than 1.8 mg/dL for more than 8 weeks. Of these 13 patients, 8 had hypertension, whereas 5 were normotensive. Due to early screening, hypertension has become the most common form of presentation in patients with ADPKD (Gabow et al., 1990b) [73] . In 1949, Rall and Odel [74] found a 73% incidence of hypertension, Dalgaard (1957) [75] , found 41% incidence, Hansson et al. (1974) [76] observed 75% incidence. Milutinovic et al. (1984) [77] reported a 33% incidence, Gabow et al. (1984) [78] found that the prevalence of hypertension was 62% in ADPKD patients. In the present study, low back pain was present in 24 (58.5%) of the patients, abdominal pain was reported by 22 (53.6%) patients (Table 2, Figure 2) . Causes of pain are multiple and can include consequences related to cysts-cyst enlargement, cyst rupture and cyst infection. Severe back, flank and abdominal pain are known con sequences of cyst enlargement in patients with polycystic kidney disease (PKD). Massive kidney and liver cysts commonly produce mechanical low back pain from exaggerated pelvic tilt and subsequent lumbar lordosis (Bajwa et al., 2001 ) [44] . In the present study, headaches were experienced by 18 (43.9%) patients (Table 3, Figure 3 ). Headaches might be due to uncontrolled hypertension in these patients. Renal stones were present in 6 (14.6%) patients in our study which is in contrast to 18% reported by Dalgaard (1957) [75] and 20% reported by Segal et al. (1977) [79] . In the present study on clinical examination ( Table  9 , Figure 7) , 24 (58.5%) patients were found to have palpable kidney and 10 (24.4%) were found to have palpable liver. Spleen was palpable in 1 (2.4%) patient, who was found to have portal hypertension leading to ascites and oesophageal varices. The murmur of mitral valve prolapse was found in 2 (4.9%) patients which was confirmed on echocardiography (Table 10, Figure 8 ).
Cerebral aneurysm is well known complication of ADPKD. The reported frequency ranges from 0% -41%. This wide variation reflects the use of different diagnostic techniques, selection biases in some studies due to evaluation only of symptomatic patients or patients with a family history of ICA, differences in racial or ethnic background and possibly the association of ICA with particularly mutations of the PKD1 or PKD2 genes that might be shared kindreds (Perrone, 1997) [80] . In the present study, no patient was found to have ICA. The reason might be that only patients with headaches were evaluated for ICA.
One of the associated manifestation of ADPKD is occurrence of cardiovascular lesions in a significant num- Table 9 ber of patients (Leier et al., 1984) [35] . In the present study, 2 (4.9%) patients were found to have mitral valve prolapse and 3 (7.3%) patients were found to have left ventricular hypertrophy. In the present study, no patient was found to have any diverticular disease. Rabbani et al. (2008) [72] also reported that none of their patients had splenic or pancreatic cyst and diverticulosis. No splenic or pancreatic cyst was detected in the present study either.
As patients with ADPKD have an increased renal mass, erythropoietin levels are increased, making anaemia unusual even when end-stage renal disease is present (Gabow et al., 1993) [33] . The mean haemoglobin in the present series was 11.2 g/dL. Blood coagulation studies and, leukocyte and platelet counts were normal.
Whether insulin resistance and elevation of serum insulin, triglycerides, low density lipoprotein and cholesterol occur in ADPKD-associated hyperension has not been ascertained. Nevertheless, reduced high density lipoprotein (HDL) and elevated LDL levels have been identified as risk factors for renal disease progression in ADPKD (Klahr et al., 1995) [81] . The level of HDL and LDL in our patients were satisfactory.
The early stages of ADPKD usually are not reflected in the urinalysis. Patients with early ADPKD may have a diminished ability to maximal concentrate the urine (Martinez- Maldonado et al., 1977) [82]. Nocturia may be the only symptom of this defect. Massive proteinuria is a rare finding (Montoyo et al., 1992) [83], and none of our patients had proteinuria in the nephrotic range. The reason of proteinuria in ADPKD is still unclear, however, possible explanation would be damage to capillary endothelium and glomerulosclerosis due to hypertension (Reckelhoff and Granger, 1999) [84] . Haematuria is usually due to rupture of a cyst into the pelvis of the kidney. Dedi et al. (2001) [85] observed that ~68% of the patients had haematuria on urinalysis.
The liver is diffusely cystic in 20% -50% of patients with ADPKD (Chauveau et al., 2000) [86] (Table 11 , Figure 9 ). The frequency of liver cysts in our series was 24.4%. Out of 10 patients with hepatic cyst involvement, 1 patient was found to have evidence of portal hypertension and one was found to have evidence of hepatic cyst infection.
Summary
The present study was conducted in the Postgraduate Department of Medicine, Government Medical College, Jammu, where a total of 41 patients-29 males and 12 females-fulfilled the criteria of ADPKD. The results of the study are summarised as follow:  Proportion of male to female patients with ADPKD was 2. patients which was confirmed on echocardiography.  3 (7.3%) patients were found to having left ventricular hypertrophy confirmed on echocardiography.  No patient was found to have ICA and valvular abnormality.  The mean haemoglobin in the present series was 11.2 g/dL.  Blood coagulation studies and, leukocyte and platelet counts were normal.  The level of HDL and LDL in our patients were satisfactory.  The liver cysts were found in 24.4% of the patients.  Out of 10 (24.4%) patients with hepatic cyst in volve- ment, 1 patient each was found to have evidence of portal hypertension and evidence of hepatic cyst infection.
Conclusion
As ADPKD is one of the common inherited renal diseases in our part of the country, more research is needed to study the pattern of this disease. In the present study, hypertension was most common presentation of this disease. So, control of hypertension is very important to prevent progression of this disease. Patients who are detected to have ADPKD should be regularly followed-up to prevent further progression by timely intervention. Also, family members of patients should be screened for disease and initiate treatment as early as possible.
